Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.435 USD | +8.75% | +0.05% | +40.78% |
May. 15 | Brookline Capital Upgrades Dare Bioscience to Buy From Hold, Price Target is $3 | MT |
May. 14 | Transcript : Daré Bioscience, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.78% | 40.23M | |
+60.83% | 62.59B | |
-2.31% | 41.18B | |
+44.42% | 40.29B | |
-8.29% | 27.9B | |
+12.47% | 26.21B | |
-21.82% | 19.09B | |
+5.33% | 13.08B | |
+24.61% | 12.26B | |
+28.02% | 12.05B |
- Stock Market
- Equities
- DARE Stock
- News Daré Bioscience, Inc.
- HC Wainwright Adjusts Dare Bioscience's Price Target to $6 from $5, Keeps Buy Rating